Immunosenescence is described as a decline in the normal functioning of the immune system associated with physiologic ageing. Immunosenescence contributes to reduced efficacy to vaccination and increased susceptibility to infectious diseases in the elderly. Extensive studies of laboratory animal models of ageing or donor lymphocyte analysis have identified changes in immunity caused by the ageing process. Most of these studies have identified phenotypic and functional changes in innate and adaptive immunity. However, it is unclear which of these defects are critical for impaired immune defense against infection. This review describes the changes that occur in innate and adaptive immunity with ageing and some age-related viral diseases where defects in a key component of immunity contribute to the high mortality rate in mouse models of ageing.
Ageing and immunosenescence
The human lifespan has significantly increased in the developed world over past decades because of socioeconomic development and medical care improvement. The global population is ageing and the proportion of elderly individuals aged 60 years and older is expected to reach 21% of the whole population by 2050 [1]. This presents a major challenge to public health services as the elderly are a vulnerable population to emerging infectious diseases, such as pandemic influenza (H5N1), West Nile virus (WNV) and severe acute respiratory syndrome (SARS) [24] . Moreover, immunosenescence renders vaccination less effective in the elderly. For example, the yearly influenza vaccine is only 29%-46% efficacious in persons aged 75 years and 41%-58% in persons 60-74 years old [5] compared to 70%-90% in young adults [4] . Additionally, reduced immune responses have been observed in elderly individuals vaccinated against tetanus, hepatitis and Streptococcus pneumonia [2] . Thus, there is an urgent need to develop strategies for improving vaccination efficacy and therapies to strengthen immunity in the elderly. However, to achieve this goal, a thorough understanding of the mechanisms underlying the age-related decline in immunity is needed.
Ageing and the adaptive immune system
Adaptive immunity includes B and T lymphocytes that respond to challenges with a high degree of specificity and memory. The competency of the adaptive immune function decreases with age. Both T cell mediated cellular immunity and B cell mediated humoral immunity are involved in immunosenescence.
Effect of ageing on T cell immunity
The age-related decline in T cell immunity is mainly characterized by a decrease in numbers of naïve T cells [6, 7] and the expansion of memory T cells, especially late-stage differentiated CD8 + cells. These result in reduced T cell TCR diversity and function [8] [9] [10] . Another feature of the T cell compartment in ageing humans or mice is the accumulation of large oligoclonal expansions of CD8 + T cells that are often cytomegalovirus (CMV)-specific [11] [12] [13] . Through longitudinal studies, Pawelec et al. [14] found that CMV seropositivity has a direct relation to immune risk phenotype (IRP). The IRP is characterized by decreasing naïve CD4 + cell numbers, an inverted ratio of CD4/CD8 cells and CD8 + T cell repertoire (TCR) disturbance [15] [16] [17] . About 60%-100% of the human population is persistently or latently infected with CMV, and chronic infection by CMV may accelerate ageing of the immune system and lead to a high levels of chronic subclinical inflammation [18] . CMVspecific CD8 + T cell expansion, resulting in a decrease of peripheral naïve CD8 + T cells and TCR diversity contraction, causes weak responses to new infectious pathogens [15, 16] . Whether other viruses, such as Epstein-Barr virus (EBV), herpesviruses (human herpesvirus, HHV) or polyomaviruses (BK virus, JC virus) may also contribute to accelerated immunosenescence in the aged population is still not fully understood [19] [20] [21] .
Another factor that contributes to immunosenescence of the T cell compartment is age-associated thymic involution. The decline in thymus function causes a dramatic decrease in naïve T cell production in aged individuals [22, 23] . This may be a good interpretation for immunosenescence, however, it cannot explain the fact that the total number of T lymphocytes is maintained quite well by homeostasis in healthy people [24, 25] . Functional and phenotypic analysis indicated that other factors probably influence the process of age-related immunosenescence. Persistent or latent virus infection or other environmental factors may be "boosting elements", but further studies are needed to investigate the impact of environmental factors on the ageing process.
Effect of ageing on B cell mediated humoral immunity
Age-associated immune dysfunction also occurs in B cell compartments, which results in impaired humoral immune functions [26, 27] . However, both naïve and memory B cells are decreased with ageing [28, 29] , in contrast with the T cell compartments. Although the percentage and number of human B cell precursors in the bone marrow do not decline significantly during ageing [30] , the total level of mature human B cells in peripheral blood significantly decreases with age [31] [32] [33] . Like T cell compartments, antigenexperienced memory cells are most prevalent in the peripheral B cell pool, resulting in limited B cell clonal expansion and repertoire diversity limitation [34, 35] [36] . The absolute number of IgM memory B cells significantly decreases as a result of the decline of total B cell numbers. However, the percentage remains unchanged. However, the percentage and number of switch memory B cells decreases during ageing [37] . Functional analysis studies have demonstrated that both IgM memory B cells and switch memory B cells are impaired in the elderly, which helps to explain why vaccines have poor effects against infections in aged people [31, 38] . Above all, antibodies secreted from B cells are also influenced by ageing. Johnson et al. [39] demonstrated that antibody affinity in aged individuals is lower than in young people, which also contributes to reduced protection from vaccination. Both humoral and cellular immune systems are affected in the ageing process, and most importantly, they are influenced reciprocally. As an integral component of the immune system, lymph nodes are the terminal point for collecting antigens from peripheral tissues and recruiting naïve lymphocytes from the blood, providing the microenvironment for primary and secondary immune responses. Therefore, the lymph node is the perfect place for studying T cell and B cell interactions. Lazuardi and colleagues demonstrated that interactions between T and B cells was impaired in aged people, leading to reduced B cell expansion and differentiation in response to antigens [40] .
Ageing and innate immunity
The innate immune system includes a diverse group of cell types including neutrophils, natural killer cells (NK), natural killer T cells (NKT), monocytes/macrophages and dendritic cells (DCs). The innate immune system, which serves as an immunological sentinel defense against microbial pathogens, is also affected at multiple levels during the ageing process [41, 42] , but the effects and mechanisms remain incompletely understood, particularly in humans. Here we discuss the recent findings in age-associated changes in NK cells.
NK cells are an important component in innate immunity, play a critical role in host defense against invading pathogens and malignant transformation through rapid cytolytic activity or direct production of cytokines, such as interferon (IFN)- and tumor necrosis factor (TNF)- [43, 44] . NK cells are derived from bone marrow. In humans, NK cells comprise about 15% of all blood lymphocytes and are defined phenotypically by their expression of CD56 surface antigen and lack of expression of CD3 [43, 45] . According to the cell surface density of CD56 and CD16 expression (FcγRIII), human NK cells can be divided into two distinct subsets, the majority (~90% in blood) of human NK cells are CD56 dim CD16 + , and a minor population (~10% in blood) is CD56 bright CD16  [45] . Early functional studies revealed that CD56 bright cells have the ability to produce abundant cytokines and have a high cytotoxic function, whereas CD56 dim cells may function as efficient effectors of natural and antibody-dependent target cell lysis [46, 47] . However, when resting NK cells were activated with interleukin (IL)-2 or IL-12 in vitro, CD56 bright and CD56 dim cells exhibited similar levels of cytotoxic ability [48, 49] .
NK cell immune functions and cellular phenotype are also influenced during ageing. Age-related changes in NK cell functionality are controversial. Previous studies focused on the cytotoxicity and numbers of NK cells in elderly people have reported different and contradictory conclusions. Recent studies have demonstrated that the number of NK cells is stable or increases during ageing [50] [51] [52] [53] [54] . In addition, the NK subpopulations are also dynamically changed during ageing. The absolute number of CD56 bright CD16
 cells declines with age and is associated with an increase in the CD56 dim CD16 + population (highly mature cytotoxic subpopulation) [55] . This change results in increased NK cytotoxicity in elderly individuals, but from a per-cell based activity analysis, cytotoxic activation decreases with age [55] [56] [57] [58] . The mechanisms of NK cell cytotoxic defects remain unknown.
Mature NK cells normally remain quiescent until virus infection or other stress. They then rapidly proliferate initially in a nonspecific mode. The cytotoxicity of activated NK cells is regulated by the balance of signals from their own activating and inhibitory receptors [59] . To date, three receptor families have been characterized, including killer cell immunoglobulin-like receptors (KIRs), natural cytotoxicity receptors (NCRs), and C-type lectins [59] [60] [61] . Recent studies have begun to elucidate age-associated changes of NK cell receptors. Lutz et al. demonstrated that the expression of KIRs is increased in the elderly population and this phenomenon is also observed in T-cell related receptor expression [6264]. In contrast, Almeida-Oliveira found no age-related changes in overall KIR expression on NK cells, but demonstrated an increase in KIR expression in the CD56 bright subset of elderly subjects instead [65] . Their results are similar to a previous report [66] . Moreover, they also found the expression of C-type lectin CD94 and activating NCRs (NKp30, NKp46) decreased significantly in older adults compared to younger adults [65] .
Once activated, NK cells exhibit direct cytolytic activity on infected cells and release pro-inflammatory cytokines and chemokines that contribute to the adaptive Th1 immune response [67] . Some limited studies have focused on the effect ageing has on the production of cytokines and the regulatory role of NK cells on adaptive immunity. Previous studies indicated that cytokines and chemokines produced by NK cells in rodents decreased with advancing age. It was observed that IL-2-induced IFN- production and IL-2-or IL-12-induced production of chemokines such as macrophage inflammatory protein 1a (MIP-1a) and IL-8 were decreased in NK cells from aged individuals [68, 69] . Mocchegiani et al. [70] showed that NK cell production of IFN-, TNF-, IL-2 and IL-12 was decreased in elderly individuals and might contribute to T cell deficits associated with ageing. However, in a recent study, IFN- production upon NK cell activation was shown to be significantly higher in the aged, particularly in subjects older than 85 years of age compared to younger adults [71] . Moreover, they found IFN--expressing NK cells correlated positively with the serum content of the -SH groups in seniors. Their findings indicated that activation of NK cells at an advanced age might be related to the oxidative and inflammatory status of the elderly.
Many factors may influence the different results in these studies regarding NK cell activity, including (i) the criteria of selected subjects (age, sex, race, etc.); (ii) the subjects' basic health and nutrition status; (iii) potential infection to virus or other pathogens; and (iv) chronic inflammation. At present, there is no standard criterion of senescence and it seems to vary with the development of the economy and subjects' physical quality. Some studies indicated that NK cell activity and cytotoxicity could be modulated by external agents such as zinc [70, 72] . Recently, "inflamm-ageing" has been described, where healthy ageing individuals have an active inflammatory state, with high levels of IL-6, IL-1 and tumor necrosis factor- (TNF-) [73] . Whether the elevation of these cytokines can regulate NK cell activity remains unknown. Clearly, we are still at the beginning of understanding the complicated changes in NK cell functions with ageing and further studies are needed to identify the mechanisms underlying these changes.
Specific defects in the immune system and age-related viral diseases
Although the defects in both the innate and adaptive immune system contribute to immunosenescence, studies have also shown that it is significantly heterogeneous in individuals. Moreover, the primary immune response is also different in the same individuals when infected with different pathogens. Experimental mice models have provided a good research platform to study age-related susceptibility to certain infectious diseases.
T cell defects and West Nile virus infection
West Nile virus (WNV) is the main cause of encephalitis in the West Nile region. The natural reservoirs for WNV are mosquitoes and birds, but it can also infect humans and other mammals [74] . There have been outbreaks and pandemics in North America and Africa and other countries in recent years [75, 76] . The mortality rate in the infected population is about 10%. WNV disease is an age-related disease. The prevalence and mortality gradually increase during ageing, and the median age of death caused by WNV is 78 years [77] . There is no protective vaccine or efficient antiviral treatment available for WNV infection. Studies have indicated that the innate immune system and T/B-cell mediated immunity are involved in the control of WNV infection. B cell-deficient mice develop high viral titers in the blood [78] . However, T cell-mediated immunity seems to play a dominant role in the control of WNV infection. T-cell defects significantly increase the lethality of WNV infection, and the survivors take many years to fully recover physical, functional and cognitive ability [79, 80] .
Using an aged mouse model, Brien et al. [81] showed that defects in T cells play a key role in age-related vulnerability to WNV infection. Aged mice infected with WNV had a high mortality rate due to uncontrolled virus spread to the brain because of CD8 and CD4 T-cell functional defects. T cell responses in aged mice following WNV infection were weak demonstrated by insufficient numbers of ineffective effector T cells accumulating in the brains of WNVinfected old mice. Both CD4 and CD8 T cells exhibited profound quantitative and qualitative defects, but these defects did not extend to all aspects of antigen recognition and activation. Furthermore, it seems that the ability of T cells to migrate into the mouse brain was not diminished, but that the infiltrating T cells had a diminished effector function [81] . Adoptive transfer of adult CD4 or CD8 T cells significantly protected aged mice against lethal WNV infection. Collectively, specific age-related defects in T cell immunity, affecting both CD8 and CD4 T cells, are the main reason for the increased susceptibility to WNV infection in the mouse model of ageing.
NK cells defects and the mousepox model
Mousepox is a viral disease caused by a specific mouse orthopoxvirus (OPV), called ectromelia virus (ECTV). ECTV is genetically very similar to the human pathogen variola virus (the agent of smallpox), and monkeypox virus (the agent of monkeypox). Monkeypox is a serious endemic disease in central Africa and a recent outbreak occurred in the USA [82, 83] . Although all mouse strains can be infected with ECTV, the outcome of the infection following footpad inoculation varies. Some sensitive strains such as BALB/c develop mousepox and endure a very high mortality rate during the first two weeks post-infection (PI) [84, 85] , while other strains such as C57BL/6 (B6) control the infection without visible symptoms. The resistance of B6 mice to disease is not due to an inherent decreased ability of the virus to replicate in this strain but to the combined action of the innate and adaptive immune systems. Deficiencies in innate immune components caused by NK cell or macrophage depletion, or deficiencies in adaptive immune components such as in CD8 T cell knockout mice, B cell knockout mice or severely immunodeficient (recombinase activating gene 1 knockout mice) mice in resistant B6 background, all readily succumb to mousepox [86] [87] [88] [89] [90] .
NK cells play an important role in controlling primary mousepox. Recently, we identified the mechanisms of NK cell mediated resistance to mousepox. After footpad ECTV infection, NK cells are activated and migrate to the local draining lymph nodes (D-LN), controlling early virus dissemination to the central organs by direct cytolytic function and by secreting anti-viral cytokines. NK cells responses also augment antiviral T cell responses [87] . Moreover, we also showed that NK cell activating receptor CD94-NKG2E can specifically recognize ECTV-infected cells, and another NK cell activating receptor NKG2D functions as a costimulator [91] .
We observed that B6 mice gradually lose their natural resistance to mousepox as they age, and that resistance starts to wane at a relatively early age (~6 months) and is completely lost when mice reach 14 months of age. Surprisingly, the main reason for the loss of resistance is not because of intrinsically defective T cell responses. Instead, the primary reason is because of defects in NK cell responses in the aged mice. We observed a decrease in the number of total and mature NK cells in the blood of aged mice [92] . In addition, after ECTV infection, mature NK cells in aged mice have an intrinsic defect in migration to the D-LN to prevent systemic virus spread. In our previous work, we demonstrated that D-LN is a major site for the prevention of viral spread [93] . Furthermore, lymph nodes are an important site for the initiation of immune responses, and where NK cells interact with other immune cells such as DCs and T cells, to regulate adaptive immune functions [94] . Therefore, our results demonstrate that NK cells from aged mice have defects in their ability to migrate to the D-LN after ECTV infection, which results in increased early virus replication and spread as well as susceptibility to an acute viral disease. A model of this is shown in Figure 1 .
In contrast to the T cell defects observed in agedependent susceptibility to WNV infection, NK cell defects directly result in the age-related susceptibility to mousepox. However, in both models, T cells and NK cells show impaired qualitative and quantitative functions. In the WNV model, the ability of T cells to migrate to the brain seems not to be defective; whereas in the mousepox model, mature NK cells have intrinsic defects in their migration to D-LNs. We further show that decreased CD62L expression on mature NK cells from aged mice might contribute to impaired migration. However, in both cases, the mechanisms underlying the functional defects are unknown. A comparison of the two models is summarized in Table 1 .
Conclusion
Clearly, immunosenescence affects both innate and adaptive immunity. The key components of the ageing immune systems for protection against infectious diseases may vary as a result of different viruses, the infection route and dose. Although significant progress has been made in recent years, results from different experimental models and different subjects are not always consistent, and can show opposing results. Understanding how and why immune responsiveness changes in humans as they age is essential for developing strategies to prevent or restore impaired immunity and assure healthy longevity. We are still at the beginning of unraveling the mystery of immunosenescence. The knowledge we gain from further in depth studies will pave the way for rational interventions to maintain or restore appropriate immune function in the elderly.
